Results · Apr-Jun 2026
Kronox Lab Sciences Q1 FY27 results
Sales grew 17% to ₹28.4 crore from ₹24.3 crore in Apr-Jun 2025.
Operating profit grew 13% to ₹9 crore, an operating margin of 31.7% (down 1.1 points from a year ago).
Net profit grew 16% to ₹7.3 crore from ₹6.3 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +9%, net profit −9%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 28.4 | 24.3 | +17% |
| Operating profit (EBITDA) | 9.0 | 8.0 | +13% |
| Operating margin | 31.7% | 32.8% | −1.1 pts |
| Net profit | 7.3 | 6.3 | +16% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.